Recent Advances in the Management of Invasive Candidiasis: Role of AnidulafunginVISCOLI, Claudio.Drugs (Basel). 2009, Vol 69, issn 0012-6667, 107 p., SUP1Serial Issue

Anidulafungin, a New Echinocandin: Effectiveness and TolerabilityMENICHETTI, Francesco.Drugs (Basel). 2009, Vol 69, pp 95-97, issn 0012-6667, 3 p., SUP1Article

Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown originMARTINO, Rodrigo; VISCOLI, Claudio.British journal of haematology. 2006, Vol 132, Num 2, pp 138-154, issn 0007-1048, 17 p.Article

Clinical Aspects of Invasive Candidiasis in the Surgical PatientSGANGA, Gabriele.Drugs (Basel). 2009, Vol 69, pp 29-32, issn 0012-6667, 4 p., SUP1Article

Candida Colonization and Candiduria in Critically Ill Patients in the Intensive Care UnitVIALE, Pierluigi.Drugs (Basel). 2009, Vol 69, pp 51-57, issn 0012-6667, 7 p., SUP1Article

Invasive Fungal Infections: The Challenge ContinuesGULLO, Antonino.Drugs (Basel). 2009, Vol 69, pp 65-73, issn 0012-6667, 9 p., SUP1Article

Clinical Aspects of Invasive Candidiasis: Endocarditis and Other Localized InfectionsVENDITTI, Mario.Drugs (Basel). 2009, Vol 69, pp 39-43, issn 0012-6667, 5 p., SUP1Article

A European organization for research and treatment of cancer-international antimicrobial therapy group study of secondary infections in febrile, neutropenic patients with cancerAKOVA, Murat; PAESMANS, Marianne; CALANDRA, Thierry et al.Clinical infectious diseases. 2005, Vol 40, Num 2, pp 239-245, issn 1058-4838, 7 p.Article

Galactomannan in piperacillin-tazobactam : How much and to what extent?MACHETTI, Marco; FURFARO, Elisa; VISCOLI, Claudio et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 9, pp 3984-3985, issn 0066-4804, 2 p.Article

Pseudomonas aeruginosa Serious Infections : Mono or Combination Antimicrobial Therapy?BASSETTI, Matteo; RIGHI, Elda; VISCOLI, Claudio et al.Current medicinal chemistry. 2008, Vol 15, Num 5, pp 517-522, issn 0929-8673, 6 p.Article

Clinical Aspects of Invasive Candidiasis in Paediatric PatientsCASTAGNOLA, Elio; BURATTI, Silvia.Drugs (Basel). 2009, Vol 69, pp 45-50, issn 0012-6667, 6 p., SUP1Article

Vancomycin susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia isolates in an Italian hospitalBASSETTI, Matteo; MESINI, Alessio; MOLINARI, Maria Pia et al.International journal of antimicrobial agents (Print). 2011, Vol 38, Num 5, pp 453-454, issn 0924-8579, 2 p.Article

Current Status of Newer CarbapenemsBASSETTI, Matteo; NICOLINI, Laura; ESPOSITO, Silvano et al.Current medicinal chemistry. 2009, Vol 16, Num 5, pp 564-575, issn 0929-8673, 12 p.Article

Epidemiology, Incidence and Risk Factors for Invasive Candidiasis in High-Risk PatientsCONCIA, Ercole; AZZINI, Anna Maria; CONTI, Michela et al.Drugs (Basel). 2009, Vol 69, pp 5-14, issn 0012-6667, 10 p., SUP1Article

Conditions associated with infections of indwelling central venous catheters in cancer patients: A summaryCASTAGNOLA, Ello; MOLINARI, Angelo Claudio; FRATINO, Giuzeppe et al.British journal of haematology. 2003, Vol 121, Num 2, pp 233-239, issn 0007-1048, 7 p.Article

Managing invasive fungal infections: relying on clinical instincts or on a rational navigation system?DE PAUW, Ben E; VISCOLI, Claudio.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, issn 0305-7453, i55-i58, SUP1Article

Management of febrile neutropenia : Current strategiesBODEY, Gerald; ROLSTON, Kenneth V. I; SEPKOWITZ, Kent et al.Clinical infectious diseases. 2005, Vol 40, pp S257-S258, issn 1058-4838, SUP4Article

High-dose daptomycin in documented Staphylococcus aureus infectionsBASSETTI, Matteo; NICCO, Elena; GINOCCHIO, Francesca et al.International journal of antimicrobial agents (Print). 2010, Vol 36, Num 5, pp 459-461, issn 0924-8579, 3 p.Article

The Role of the Laboratory in the Diagnosis of Invasive CandidiasisMONTAGNA, Maria Teresa; CAGGIANO, Giuseppina; BORGHI, Elisa et al.Drugs (Basel). 2009, Vol 69, pp 59-63, issn 0012-6667, 5 p., SUP1Article

Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy—EORTC Infectious Diseases Group Trial XVKERN, Winfried V; MARCHETTI, Oscar; DRGONA, Lubos et al.Journal of clinical oncology. 2013, Vol 31, Num 9, pp 1149-1156, issn 0732-183X, 8 p.Article

Galactomannan testing might be useful for early diagnosis of fusariosisMIKULSKA, Małgorzata; FURFARO, Elisa; VISCOLI, Claudio et al.Diagnostic microbiology and infectious disease. 2012, Vol 72, Num 4, pp 367-369, issn 0732-8893, 3 p.Article

Voriconazole in clinical practiceMIKULSKA, Małgorzata; NOVELLI, Andrea; AVERSA, Franco et al.Journal of chemotherapy (Testo stampato). 2012, Vol 24, Num 6, pp 311-327, issn 1120-009X, 17 p.Article

A multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancerCASTAGNOLA, Elio; BONI, Luca; BRUZZI, Paolo et al.The Pediatric infectious disease journal. 2003, Vol 22, Num 4, pp 359-365, issn 0891-3668, 7 p.Article

Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniaeTUMBARELLO, Mario; TRECARICHI, Enrico Maria; GIANNELLA, Maddalena et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 6, pp 3514-3520, issn 0066-4804, 7 p.Article

Page / 2